HUTCHMED (China) Limited

Contributing Author

Recent Articles by HUTCHMED (China) Limited

Jul-03	HUTCHMED to Announce 2025 Half-Year Financial Results HCM GlobeNewswire
Jun-30	HUTCHMED Announces China Approval for ORPATHYS in Combination with TAGRISSO for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy HCM GlobeNewswire
Jun-04	HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma HCM GlobeNewswire
Jun-01	HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting HCM GlobeNewswire
May-22	HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting HCM GlobeNewswire